Company Profile
Yichang Borenpharm Co., Ltd. was established in August 2019, which mainly produces PEG linkER type linker products, which are popular internationally, and also develops and produces PEG linkER modified nanoliposome formulations and lipophilic nanoparticle formulations, which provide reliable materials and technical support for the drug delivery industry that is in urgent need at home and abroad. The drug delivery intermediates developed by Yichang Borenpharm Co., Ltd. are designed to utilize existing nanoparticle guidance technology to achieve rapid combination of existing target molecules and existing therapeutic agents (using our PEG linker technology), thus allowing rapid development of a drug library of thousands of target molecule-guided therapeutic agents. The drug library of thousands of targeted molecule-guided therapeutic agents can then be combined with clinical therapies, allowing for the screening of the most appropriate medical agents for the treatment of patients, thus enabling optimal personalized treatment of patients.
WeChat Official Account
© COPYRIGHT 2022 Yichang Borenpharm Co., Ltd.. ALL RIGHTS RESERVED | SEO | Power by 300.cn
